{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:34:10Z","timestamp":1740123250080,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China Grant","doi-asserted-by":"crossref","award":["81770943","81470651"],"award-info":[{"award-number":["81770943","81470651"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National key research and development program","doi-asserted-by":"crossref","award":["2016YFC0904801","2017YFC0111204"],"award-info":[{"award-number":["2016YFC0904801","2017YFC0111204"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Fund for Science and Technology Program of Beijing","award":["Z171100002217081","Z161100000516037"],"award-info":[{"award-number":["Z171100002217081","Z161100000516037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10792-019-01261-y","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T10:03:56Z","timestamp":1578650636000},"page":"951-956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy"],"prefix":"10.1007","volume":"40","author":[{"given":"Dandan","family":"Linghu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaojun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lvzhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"issue":"2","key":"1261_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","volume":"86","author":"M Wang","year":"2008","unstructured":"Wang M, Munch IC, Hasler PW et al (2008) Central serous chorioretinopathy. Acta Ophthalmol 86(2):126\u2013145","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"1261_CR2","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/eye.2010.130","volume":"24","author":"M Gemenetzi","year":"2010","unstructured":"Gemenetzi M, De Salvo G, Lotery AJ (2010) Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (London) 24(12):1743\u20131756","journal-title":"Eye (London)"},{"issue":"2","key":"1261_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","volume":"58","author":"B Nicholson","year":"2013","unstructured":"Nicholson B, Noble J, Forooghian F et al (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58(2):103\u2013126","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"1261_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00417-009-1104-8","volume":"247","author":"JW Moon","year":"2009","unstructured":"Moon JW, Yu HG, Kim TW et al (2009) Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 247(10):1315\u20131323","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"1261_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ophtha.2014.09.026","volume":"122","author":"EK de Jong","year":"2015","unstructured":"de Jong EK, Breukink MB, Schellevis RL et al (2015) Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. Ophthalmology 122(3):562\u2013570","journal-title":"Ophthalmology"},{"issue":"5","key":"1261_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ophtha.2013.11.020","volume":"121","author":"A Miki","year":"2014","unstructured":"Miki A, Kondo N, Yanagisawa S et al (2014) Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy. Ophthalmology 121(5):1067\u20131072","journal-title":"Ophthalmology"},{"issue":"2","key":"1261_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/IAE.0000000000000693","volume":"36","author":"MM Moschos","year":"2016","unstructured":"Moschos MM, Gazouli M, Gatzioufas Z et al (2016) Prevalence of the complement factor H and GSTM1 genes polymorphisms in patients with central serous chorioretinopathy. Retina 36(2):402\u2013407","journal-title":"Retina"},{"key":"1261_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/eye.2015.32","volume":"29","author":"L Huang","year":"2015","unstructured":"Huang L, Meng Q, Zhang C et al (2015) Gene-gene interaction of CFH, ARMS2, and ARMS2\/HTRA1 on the risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese population. Eye 29:691\u2013698","journal-title":"Eye"},{"issue":"2","key":"1261_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1442-9071.2012.02847.x","volume":"41","author":"G Quin","year":"2013","unstructured":"Quin G, Liew G, Ho IV et al (2013) Diagnosis and interventions for central serous chorioretinopathy: review and update. Clin Exp Ophthalmol 41(2):187\u2013200","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"1261_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ajo.2009.11.017","volume":"149","author":"LA Yannuzzi","year":"2010","unstructured":"Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149(3):361\u2013363","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1261_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jamaophthalmol.2014.5312","volume":"133","author":"M Zhao","year":"2015","unstructured":"Zhao M, Zhang F, Chen Y et al (2015) A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial. JAMA Ophthalmol 133(3):333\u2013340","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"1261_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2015.04.011","volume":"160","author":"YK Kim","year":"2015","unstructured":"Kim YK, Ryoo NK, Woo SJ et al (2015) Choroidal thickness changes after photodynamic therapy and recurrence of chronic central serous chorioretinopathy. Am J Ophthalmol 160(1):72\u201384","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"1261_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/OPX.0000000000000360","volume":"91","author":"MJ Tsai","year":"2014","unstructured":"Tsai MJ, Hsieh YT (2014) Half-time photodynamic therapy for central serous chorioretinopathy. Optom Vis Sci 91(9):1140\u20131145","journal-title":"Optom Vis Sci"},{"issue":"7","key":"1261_CR14","doi-asserted-by":"publisher","first-page":"e0181479","DOI":"10.1371\/journal.pone.0181479","volume":"12","author":"F Haga","year":"2017","unstructured":"Haga F, Maruko R, Sato C et al (2017) Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: a 3-year follow-up study. PLoS ONE 12(7):e0181479","journal-title":"PLoS ONE"},{"issue":"4","key":"1261_CR15","first-page":"67","volume":"1","author":"L Siaudvytyte","year":"2012","unstructured":"Siaudvytyte L, Diliene V, Miniauskiene G et al (2012) Photodynamic therapy and central serous chorioretinopathy. Med Hypothesis Discovery Innov Ophthalmol J 1(4):67\u201371","journal-title":"Med Hypothesis Discovery Innov Ophthalmol J"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01261-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-019-01261-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01261-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:06:33Z","timestamp":1610150793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-019-01261-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1007\/s10792-019-01261-y","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"type":"print","value":"0165-5701"},{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2020,1,10]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Peking University people\u2019s hospital research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}